1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

Cell lines tested with navitoclax:sorafenib (1:1 mol/mol)

835 cell lines have been tested with this compound, using data from 1 dataset(s).
2004 N/A CTRPv21
22RV1 prostate CTRPv21
23132-87 stomach CTRPv21
42-MG-BA central nervous system CTRPv21
5637 urinary tract CTRPv21
639-V urinary tract CTRPv21
647-V urinary tract CTRPv21
697 haematopoietic and lymphoid tissue CTRPv21
769-P kidney CTRPv21
786-0 kidney CTRPv21
Download CSV

Tissues tested with navitoclax:sorafenib (1:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
central nervous systemCTRPv247
breastCTRPv236
stomachCTRPv231
urinary tractCTRPv222
biliary tractCTRPv26
haematopoietic and lymphoid tissueCTRPv2154
autonomic gangliaCTRPv213
liverCTRPv222
kidneyCTRPv220
pleuraCTRPv28
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP33 CTRPv2 AAC 0.33 2e-20
mRNA TUBA1A CTRPv2 AAC 0.3 2e-14
mRNA RP11-729L2.2 CTRPv2 AAC 0.29 2e-14
mRNA SMAD4 CTRPv2 AAC 0.28 2e-14
mRNA GOLGA8M CTRPv2 AAC 0.26 2e-14
mRNA CELF4 CTRPv2 AAC 0.28 2e-14
mRNA PRR36 CTRPv2 AAC 0.28 6e-14
mRNA HDHD2 CTRPv2 AAC 0.28 7e-14
mRNA TIFAB CTRPv2 AAC 0.25 8e-14
mRNA CRMP1 CTRPv2 AAC 0.3 9e-14
Download CSV